TrialAmerican journal of hematology2024

Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study.

James F Casella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.